Literature DB >> 29287807

Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.

Eric Davis1, Sean Devlin2, Candice Cooper3, Melissa Nhaissi1, Jennifer Paulson3, Deborah Wells1, Andromachi Scaradavou1, Sergio Giralt4, Esperanza Papadopoulos4, Nancy A Kernan1, Courtney Byam1, Juliet N Barker5.   

Abstract

A strategy to rapidly determine if a matched unrelated donor (URD) can be secured for allograft recipients is needed. We sought to validate the accuracy of (1) HapLogic match predictions and (2) a resultant novel Search Prognosis (SP) patient categorization that could predict 8/8 HLA-matched URD(s) likelihood at search initiation. Patient prognosis categories at search initiation were correlated with URD confirmatory typing results. HapLogic-based SP categorizations accurately predicted the likelihood of an 8/8 HLA-match in 830 patients (1530 donors tested). Sixty percent of patients had 8/8 URD(s) identified. Patient SP categories (217 very good, 104 good, 178 fair, 33 poor, 153 very poor, 145 futile) were associated with a marked progressive decrease in 8/8 URD identification and transplantation. Very good to good categories were highly predictive of identifying and receiving an 8/8 URD regardless of ancestry. Europeans in fair/poor categories were more likely to identify and receive an 8/8 URD compared with non-Europeans. In all ancestries very poor and futile categories predicted no 8/8 URDs. HapLogic permits URD search results to be predicted once patient HLA typing and ancestry is obtained, dramatically improving search efficiency. Poor, very poor, andfutile searches can be immediately recognized, thereby facilitating prompt pursuit of alternative donors.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Search categorization; Unrelated donors

Mesh:

Year:  2017        PMID: 29287807      PMCID: PMC5953787          DOI: 10.1016/j.bbmt.2017.12.791

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  21 in total

Review 1.  Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation?

Authors:  Claudio Anasetti; Franco Aversa; Claudio G Brunstein
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

2.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

3.  HapLogic: A Predictive Human Leukocyte Antigen-Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources for Transplantation.

Authors:  Jason Dehn; Michelle Setterholm; Kelly Buck; Jane Kempenich; Beth Beduhn; Loren Gragert; Abeer Madbouly; Stephanie Fingerson; Martin Maiers
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-02       Impact factor: 5.742

Review 4.  Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.

Authors:  Karen K Ballen; John Koreth; Yi-Bin Chen; Bimalangshu R Dey; Thomas R Spitzer
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

5.  Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Authors:  John Horan; Tao Wang; Michael Haagenson; Stephen R Spellman; Jason Dehn; Mary Eapen; Haydar Frangoul; Vikas Gupta; Gregory A Hale; Carolyn K Hurley; Susana Marino; Machteld Oudshoorn; Vijay Reddy; Peter Shaw; Stephanie J Lee; Ann Woolfrey
Journal:  Blood       Date:  2012-07-24       Impact factor: 22.113

6.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

7.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.

Authors:  Filippo Milano; Ted Gooley; Brent Wood; Ann Woolfrey; Mary E Flowers; Kristine Doney; Robert Witherspoon; Marco Mielcarek; Joachim H Deeg; Mohamed Sorror; Ann Dahlberg; Brenda M Sandmaier; Rachel Salit; Effie Petersdorf; Frederick R Appelbaum; Colleen Delaney
Journal:  N Engl J Med       Date:  2016-09-08       Impact factor: 91.245

8.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

9.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

10.  Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem cell transplant in adult patients with acute myeloid leukemia in first and second complete remission.

Authors:  Rada M Grubovikj; Asif Alavi; Ahrin Koppel; Mary Territo; Gary J Schiller
Journal:  Cancers (Basel)       Date:  2012-06-20       Impact factor: 6.639

View more
  6 in total

1.  Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching.

Authors:  Katharina Fleischhauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

Authors:  Joseph Pidala; Tatenda G Mupfudze; Tammy Payton; Juliet Barker; Miguel-Angel Perales; Bronwen E Shaw; Marcelo Fernández-Viña; Linda J Burns; Jason Dehn
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-13       Impact factor: 5.742

3.  Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mary Joseph Acevedo; Jennifer S Wilder; Sharon Adams; Joie Davis; Corin Kelly; Dianne Hilligoss; Ellen Carroll; Bazetta Blacklock-Schuver; Kristen Cole; Elizabeth M Kang; Amy P Hsu; Christopher G Kanakry; Dimana Dimitrova; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-12       Impact factor: 5.742

4.  Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.

Authors:  Juliet N Barker; Kirsten Boughan; Parastoo B Dahi; Sean M Devlin; Molly A Maloy; Kristine Naputo; Christopher M Mazis; Eric Davis; Melissa Nhaissi; Deborah Wells; Candice Cooper; Doris M Ponce; Nancy Kernan; Andromachi Scaradavou; Sergio A Giralt; Esperanza B Papadopoulos; Ioannis Politikos
Journal:  Blood Adv       Date:  2019-04-09

Review 5.  Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.

Authors:  Jason Dehn; Stephen Spellman; Carolyn K Hurley; Bronwen E Shaw; Juliet N Barker; Linda J Burns; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Robert Hartzman; Martin Maiers; Susana R Marino; Carlheinz Mueller; Miguel-Angel Perales; Raja Rajalingam; Joseph Pidala
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

6.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.